{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:44:18Z","timestamp":1782902658288,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007765","name":"Shenyang Science and Technology Bureau","doi-asserted-by":"publisher","award":["2400023046"],"award-info":[{"award-number":["2400023046"]}],"id":[{"id":"10.13039\/501100007765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2021-46-2101"],"award-info":[{"award-number":["Z-2021-46-2101"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital of China Medical University","doi-asserted-by":"publisher","award":["M1312"],"award-info":[{"award-number":["M1312"]}],"id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijbiomac.2024.139275","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:29:59Z","timestamp":1735327799000},"page":"139275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Improved epirubicin delivery selectivity to bladder cancer achieved by functionalized hydroxyethyl starch-based prodrug"],"prefix":"10.1016","volume":"293","author":[{"given":"Xiaohan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0005","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2017.08.120","article-title":"Advances in intravesical drug delivery systems to treat bladder cancer","volume":"532","author":"Kolawole","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0015","first-page":"44","article-title":"U.A.o.C.R.H.A.U.-H.P.A.o.C.I.E.P.A.f.M.H.C. the Chinese Urological Doctor Association, Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)","volume":"9","author":"Jin","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106330","article-title":"LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy","volume":"180","author":"Anzengruber","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"19","key":"10.1016\/j.ijbiomac.2024.139275_bb0025","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.139275_bb0030","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.2015.64.4070","article-title":"Definitions, end points, and clinical trial designs for non\u2013muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group","volume":"34","author":"Kamat","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.139275_bb0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139275_bb0045","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","volume":"57","author":"Sylvester","year":"2010","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.139275_bb0050","first-page":"326","article-title":"A randomized controlled study of intravesical instillation therapy of Bacillus Calmette-Gu\u00e9rin vs. epirubicinin treating non-muscular invasive bladder cancer","volume":"52","author":"Yang","year":"2021","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.139275_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202200342","article-title":"Mannose-targeting concanavalin A-epirubicin conjugate for targeted intravesical chemotherapy of bladder cancer","volume":"17","author":"Huo","year":"2022","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jconrel.2022.05.031","article-title":"Bladder cancer selective chemotherapy with potent NQO1 substrate co-loaded prodrug nanoparticles","volume":"347","author":"Jiao","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0065","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2147\/IJN.S189688","article-title":"Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer","volume":"14","author":"Suo","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0070","article-title":"Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease","volume":"87","author":"Mustafa","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13287-023-03309-4","article-title":"Application of mesenchymal stem cell sheet for regeneration of craniomaxillofacial bone defects","volume":"14","author":"Banimohamad-Shotorbani","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.139275_bb0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1039\/D3TB01786A","article-title":"Biomedical applications of cerium vanadate nanoparticles: a review","volume":"12","author":"Farasati Far","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15171\/apb.2017.017","article-title":"Preparation, optimization and activity evaluation of PLGA\/streptokinase nanoparticles using electrospray","volume":"7","author":"Yaghoobi","year":"2017","journal-title":"Adv. Pharm. Bull."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.139275_bb0090","doi-asserted-by":"crossref","first-page":"14816","DOI":"10.1021\/acsami.0c22381","article-title":"State-of-the-art of nanodiagnostics and nanotherapeutics against SARS-CoV-2","volume":"13","author":"Derakhshan","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.139275_bb0095","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-12-2101","article-title":"Targeting folate receptors to treat invasive urinary bladder cancer","volume":"73","author":"Dhawan","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biomaterials.2016.11.030","article-title":"Targeted hydroxyethyl starch prodrug for inhibiting the growth and metastasis of prostate cancer","volume":"116","author":"Zhao","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0105","doi-asserted-by":"crossref","unstructured":"Q. Pan, G.-L. Yang, J.-H. Yang, S.-L. Lin, N. Liu, S.-S. Liu, M.-Y. Liu, L.-H. Zhang, Y.-R. Huang, R.-l. Shen, Q. Liu, J.-X. Gao, J.-J. Bo, Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways, J. Exp. Clin. Cancer Res. 34 (2015) 77.","DOI":"10.1186\/s13046-015-0183-0"},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2016.12.041","article-title":"Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma","volume":"259","author":"Guo","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2014.06.083","article-title":"Urology, transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream - ScienceDirect","volume":"193","author":"Helgi","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.actbio.2017.08.025","article-title":"Improved tumor tissue penetration and tumor cell uptake achieved by delayed charge reversal nanoparticles","volume":"62","author":"Gou","year":"2017","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.139275_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24833","article-title":"Dual-targeting CD44 and mucin by hyaluronic acid and 5TR1 aptamer for epirubicin delivery into cancer cells: synthesis, characterization, in vitro and in vivo evaluation","volume":"10","author":"Jamshidi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133121","article-title":"Preparation of novel sulfated polysaccharide-carboxymethyl-5-fluorouracil-folic acid conjugates for targeted anticancer drug delivery","volume":"273","author":"Ma","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129901","article-title":"Stimuli responsiveness of recent biomacromolecular systems (concept to market): a review","volume":"261","author":"Singh","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121683","article-title":"Folate decorated chitosan-chondroitin sulfate nanoparticles loaded hydrogel for targeting macrophages against rheumatoid arthritis","volume":"327","author":"Siddiqui","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124032","article-title":"Dual size\/charge-switchable and multi-responsive gelatin-based nanocluster for targeted anti-tumor therapy","volume":"238","author":"Xiao","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122358","article-title":"A new modality in targeted delivery of epirubicin for tumor theranosis based on PEGylated silver nanoparticles: design, radiolabeling and bioevaluation","volume":"629","author":"Abdel-Hameed","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139275_bb0155","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.apsb.2024.02.006","article-title":"Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139275_bb0160","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s11095-014-1573-2","article-title":"Release, partitioning, and conjugation stability of doxorubicin in polymer micelles determined by mechanistic modeling","volume":"32","author":"Ponta","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105026","article-title":"Interpreting non-linear drug diffusion data: utilizing Korsmeyer-Peppas model to study drug release from liposomes","volume":"138","author":"Wu","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0170","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1021\/bm401526d","article-title":"Dextran-based doxorubicin nanocarriers with improved tumor penetration","volume":"15","author":"Sagnella","year":"2014","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.139275_bb0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10654-006-9101-2","article-title":"Measurement of urine pH for epidemiological studies on bladder cancer","volume":"22","author":"Alguacil","year":"2007","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.139275_bb0180","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/UPJ.0000000000000576","article-title":"Establishing an intravesical doublet chemotherapy clinic for nonmuscle-invasive bladder cancer patients","volume":"11","author":"Abou Chakra","year":"2024","journal-title":"Urol. Pract."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.139275_bb0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11095-021-02989-y","article-title":"Folic acid-doxorubicin-double-functionalized-lipid-core nanocapsules: synthesis, chemical structure elucidation, and cytotoxicity evaluation on ovarian (OVCAR-3) and bladder (T24) cancer cell lines","volume":"38","author":"C\u00e9","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0190","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.2147\/IJN.S260477","article-title":"Self-assembled dual-targeted epirubicin-hybrid polydopamine nanoparticles for combined chemo-photothermal therapy of triple-negative breast cancer","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139275_bb0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/10837450.2020.1725045","article-title":"Folate conjugation improved uptake and targeting of porous hydroxyapatite nanoparticles containing epirubicin to cancer cells","volume":"25","author":"Ansari","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fonc.2020.00265","article-title":"Perplexing role of P-glycoprotein in tumor microenvironment","volume":"10","author":"Robinson","year":"2020","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139275_bb0205","first-page":"5652","article-title":"Role of 5-Aza-CdR in mitomycin-C chemosensitivity of T24 bladder cancer cells","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijbiomac.2024.139275_bb0210","series-title":"Urothelial Carcinoma: Methods and Protocols","first-page":"155","article-title":"The N-butyl-N-4-hydroxybutyl nitrosamine mouse urinary bladder cancer model","author":"Oliveira","year":"2018"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.139275_bb0215","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/mp100038h","article-title":"The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles","volume":"7","author":"Lee","year":"2010","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139275_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41420-024-02095-z","article-title":"Epirubicin induces cardiotoxicity through disrupting ATP6V0A2-dependent lysosomal acidification and triggering ferroptosis in cardiomyocytes","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.139275_bb0225","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1039\/D3TB02837B","article-title":"Hydrogel: a new material for intravesical drug delivery after bladder cancer surgery","volume":"12","author":"Wu","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.139275_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188025","article-title":"Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity","volume":"12","author":"Yang","year":"2017","journal-title":"PloS One"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024100864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024100864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:49:45Z","timestamp":1782899385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024100864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":46,"alternative-id":["S0141813024100864"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139275","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved epirubicin delivery selectivity to bladder cancer achieved by functionalized hydroxyethyl starch-based prodrug","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"139275"}}